CLINICAL CASE DISCUSSIONSSynthetic Cannabinoids Use in Elderly PatientsMAHGOUB, NAHLA MD; YOUNG, ROBERT C. MD Author Information MAHGOUB: Clinical Assistant Professor of Psychiatry, Weill Cornell Medicine, New York; YOUNG: Professor of Psychiatry, Weill Cornell Medicine, White Plains, NY The authors declare no conflicts of interest. Please send correspondence to: Nahla Mahgoub, MD, Clinical Assistant Professor of Psychiatry, Weill Cornell Medicine, 1300 York Avenue, New York, NY 10065 ([email protected]). Journal of Psychiatric Practice: May 2017 - Volume 23 - Issue 3 - p 230-232 doi: 10.1097/PRA.0000000000000232 Buy Metrics Abstract Synthetic cannabinoids are becoming a public health concern. No data are apparently available concerning use of synthetic cannabinoids in the elderly. We report two cases of elderly individuals who used synthetic cannabinoids and were admitted to a psychiatric hospital. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.